UnknownNCT07611448

An Observational Study of Artificial Intelligence-Assisted Blastocyst Morphokinetic Analysis Using Short-Duration Video and Its Association With Pregnancy Outcomes

Sponsor: Viable Biosciences

Trial Details

ConditionInfertility Assisted Reproductive Technology, Infertility (IVF Patients)
StatusUnknown
Participants1,000
Est. Completion31 Dec 2028
Last Updated28 May 2026

Primary Outcome

Ongoing Clinical Pregnancy

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Signed Inform Consent * Ages between 18 and 45 years * Patients using own or donated eggs * Patients undergoing assisted reproduction procedures (ICSI with Embryo Transfer, Frozen Embryo Transfers with or without PGT-A receiving a single embryo transfer. * Patients with at least one embryo at the blastocyst stage on day 5, day 6 or day 7 of embryo development. * Patients using a surrogate carrier for the embryo transfer procedure. * Patients with Abnormal Embryos after PGT-A to be discarded. * Patients with Euploid Embryos after PGT-A to be discarded Exclusion Criteria: * Absence of viable embryos at the blastocyst stage. * Any uterine abnormalities that could affect embryo implantation.

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service